Login / Signup

Long-term outcomes of phenoclusters in preclinical heart failure with preserved and mildly reduced ejection fraction.

Luca FazziniArianna GhirardiRaul LimontaAlice CalabreseEmilia D'EliaPaolo CanovaAlessandra FontanaAurelia GrosuAttilio IacovoniPaola FerrariRenata De MariaAntonello GavazziRoberta MontisciMichele SenniMauro Gori
Published in: ESC heart failure (2024)
Based on phenomapping, older patients with lower kidney function and worse diastolic function might represent a subset of preclinical HF with EF > 40% who deserve more efforts to prevent clinical HF.
Keyphrases
  • heart failure
  • acute heart failure
  • left ventricular
  • cell therapy
  • blood pressure
  • physical activity
  • middle aged
  • quality improvement
  • ejection fraction
  • stem cells
  • bone marrow